Hvilken er prisen på Oscotec Inc. (039200)

Prisen på Oscotec Inc. (039200) er $24.76

Hva er markedsverdien på Oscotec Inc. (039200)

Markedsverdien på Oscotec Inc. (039200) er $947.10M

Oscotec Inc. (039200) Fortjeneste per Aksje

Oscotec Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutic drugs. Its primary focus lies in advancing a pipeline of investigational medicines, including a SYK inhibitor currently in Phase IIa clinical trials for the treatment of both rheumatoid arthritis and immune thrombocytopenia. Another key asset is an FLT3 inhibitor, undergoing Phase I clinical evaluation for acute myeloid leukemia. The company is also developing an EGFR double mutation inhibitor aimed at non-small cell lung cancer, and an Anti-Tau antibody in the preclinical stage for Alzheimer's disease. Beyond its pharmaceutical endeavors, Oscotec Inc. diversifies its offerings with a range of dental health products, such as bone graft materials like InduCera, BioCera-F, and SynCeraII, alongside membranes including LysoGide and CollaGuide. Additionally, it markets functional ingredients designed to address specific health concerns, such as OPB for osteoporosis, AIF for arthritis, SGA for enhancing bone growth, and PRF-K for periodontal conditions. Established in 1988, the company, originally known as Oscotec Co., Ltd, adopted its current name, Oscotec Inc., in June 1999. It is headquartered in Seongnam, South Korea.

År	EPS	Endre
Ikke nok data for de angitte datoene.

År

EPS

Endre

Ikke nok data for de angitte datoene.

Selskap	EPS	EPS-forskjell	Land
Eli Lilly and Company LLY.US	$29.85	-	US
Johnson & Johnson JNJ.US	$8.65	-	US
AbbVie Inc. ABBV.US	$3.55	-	US
Roche Holding AG RO.SW	$20.39	-	CH
Merck & Co., Inc. MRK.US	$1.26	-	US

Selskap

EPS

EPS-forskjell

Land

Eli Lilly and Company

LLY.US

$29.85

Johnson & Johnson

JNJ.US

$8.65

AbbVie Inc.

ABBV.US

$3.55

Roche Holding AG

RO.SW

$20.39

Merck & Co., Inc.

MRK.US

$1.26

Oscotec Inc.

039200

Kategori